Pharmacy

GlaxoSmithKline and Merck have partnered to develop and commercialize a cancer immunotherapy treatment in a deal that could be valued at $4.2 billion, Bloomberg reports.

Hedge fund Appaloosa LP is placing more pressure on Allergan to separate the roles of chairman and CEO in an effort to address the drugmaker's underperformance.

ProvideGx, a company established by Premier in January to address generic drug shortages, will start with manufacturing a blood pressure medication that has been hard to obtain.

PillPack, the online pharmacy startup purchased by Amazon last year, has obtained nine additional state pharmacy licenses in the last two months, according to Med City News.

Rochester, Minn.-based Mayo Clinic's planned $8 million pharmacy will primarily focus on mail-order prescriptions and will not be used for public use, according to the Post Bulletin.

The Pistoia Alliance, a nonprofit alliance focused on driving research and development efforts in the life sciences industry, launched the next phase of its blockchain project Feb. 6.

Chicago-based Novum Pharma filed for Chapter 11 bankruptcy Feb. 1, and plans to sell its assets, according to The Wall Street Journal.

Drugmaker Gilead Sciences turned around a net loss in the fourth quarter of fiscal year 2018, but saw its expenses rise due to research and development costs.

The Senate Finance Committee on Feb. 4 invited leaders from seven major drug companies to testify at a hearing about high prescription drug costs later this month, reports Reuters.

An abrupt shortage of the anti-anxiety drug buspirone is complicating mental healthcare for many patients, reports The New York Times.